Please login to the form below

Not currently logged in
Email:
Password:

endometrial cancer

This page shows the latest endometrial cancer news and features for those working in and with pharma, biotech and healthcare.

GSK’s Jemperli combination shows promise in phase 3 endometrial cancer trial

GSK’s Jemperli combination shows promise in phase 3 endometrial cancer trial

Up to 20% of endometrial cancer patients will have advanced disease at the time of diagnosis. ... Jemperli currently has regulatory approvals to treat specific subtypes of advanced or recurrent endometrial cancer.

Latest news

More from news
Approximately 12 fully matching, plus 18 partially matching documents found.

Latest from PMHub

  • The power of influence in transforming women’s health The power of influence in transforming women’s health

    HRT continued to grow in popularity after the 1960s, particularly with research showing the links between certain doses and a reduced risk of endometrial cancer. ... iv] Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...